The Autism Impact Fund is a San Francisco-based specialist venture fund focused exclusively on investing in companies developing therapeutics, diagnostics, and support technologies for autism spectrum disorder (ASD). It is backed by a community of investors with personal connections to autism and invests at seed and Series A stages in companies where there is potential to meaningfully improve outcomes for autistic people.

ASD is deeply neurological in nature, overlapping with research in neural connectivity, sensory processing, and neurodevelopmental biology, making this fund directly relevant to neurotech companies developing tools for neurodevelopmental conditions.